ArticleBMJ open2020

Efficacy of neoadjuvant atezolizumab treatment in patients with advanced urothelial bladder cancer according to the BASQ classification: a study protocol for an open-label, two-cohort, phase II trial.

Hyeong Dong Yuk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.